5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent studies have reported that upregulation of disulfide-bond A oxidoreductase-like protein (DsbA-L) prevented lipid-induced renal injury in diabetic nephropathy (DN). However, the role and regulation of proximal tubular DsbA-L for renal tubulointerstitial fibrosis (TIF) remains unclear. In current study, we found that a proximal tubules-specific DsbA-L knockout mouse (PT-DsbA-L-KO) attenuated UUO-induced TIF, renal cell apoptosis and inflammation. Mechanistically, the DsbA-L interacted with Hsp90 in mitochondria of BUMPT cells which activated the signaling of Smad3 and p53 to produce connective tissue growth factor (CTGF) and then resulted in accumulation of ECM of BUMPT cells and mouse kidney fibroblasts. In addition, the progression of TIF caused by UUO, ischemic/reperfusion (I/R), aristolochic acid, and repeated acute low-dose cisplatin was also alleviated in PT-DsbA-L-KO mice via the activation of Hsp90 /Smad3 and p53/CTGF axis. Finally, the above molecular changes were verified in the kidney biopsies from patients with obstructive nephropathy (Ob). Together, these results suggest that DsbA-L in proximal tubular cells promotes TIF via activation of the Hsp90 /Smad3 and p53/CTGF axis.

          Abstract

          DsbA-L upregulation prevents lipid-induced renal injury in diabetic nephropathy. Here, the authors show that DsbA-L knockout attenuates tubulointerstitial fibrosis in mice, and show that this occurs via activation of Smad3 and p53, which result in modulation of CTGF, a regulator of kidney fibrosis.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway

          Chronic inflammation in adipose tissue plays a key role in obesity-induced insulin resistance. However, the mechanisms underlying obesity-induced inflammation remain elusive. Here we show that obesity promotes mtDNA release into the cytosol, where it triggers inflammatory responses by activating the DNA-sensing cGAS-cGAMP-STING pathway. Fat-specific knockout of disulfide-bond A oxidoreductase-like protein (DsbA-L), a chaperone-like protein originally identified in the mitochondrial matrix, impaired mitochondrial function and promoted mtDNA release, leading to activation of the cGAS-cGAMP-STING pathway and inflammatory responses. Conversely, fat-specific overexpression of DsbA-L protected mice against high-fat diet-induced activation of the cGAS-cGAMP-STING pathway and inflammation. Taken together, we identify DsbA-L as a key molecule that maintains mitochondrial integrity. DsbA-L deficiency promotes inflammation and insulin resistance by activating the cGAS-cGAMP-STING pathway. Our study also reveals that, in addition to its well-characterized roles in innate immune surveillance, the cGAS-cGAMP-STING pathway plays an important role in mediating obesity-induced metabolic dysfunction.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

            Smad2 and Smad3 interact and mediate TGF-beta signaling. Although Smad3 promotes fibrosis, the role of Smad2 in fibrogenesis is largely unknown. In this study, conditional deletion of Smad2 from the kidney tubular epithelial cells markedly enhanced fibrosis in response to unilateral ureteral obstruction. In vitro, Smad2 knockdown in tubular epithelial cells increased expression of collagen I, collagen III, and TIMP-1 and decreased expression of the matrix-degrading enzyme MMP-2 in response to TGF-beta1 compared with similarly treated wild-type cells. We obtained similar results in Smad2-knockout fibroblasts. Mechanistically, Smad2 deletion promoted fibrosis through enhanced TGF-beta/Smad3 signaling, evidenced by greater Smad3 phosphorylation, nuclear translocation, promoter activity, and binding of Smad3 to a collagen promoter (COL1A2). Moreover, deletion of Smad2 increased autoinduction of TGF-beta1. Conversely, overexpression of Smad2 attenuated TGF-beta1-induced Smad3 phosphorylation and collagen I matrix expression in tubular epithelial cells. In conclusion, in contrast to Smad3, Smad2 protects against TGF-beta-mediated fibrosis by counteracting TGF-beta/Smad3 signaling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Lnc-mg is a long non-coding RNA that promotes myogenesis

              Recent studies indicate important roles for long noncoding RNAs (lncRNAs) as essential regulators of myogenesis and adult skeletal muscle regeneration. However, the specific roles of lncRNAs in myogenic differentiation of adult skeletal muscle stem cells and myogenesis are still largely unknown. Here we identify a lncRNA that is specifically enriched in skeletal muscle (myogenesis-associated lncRNA, in short, lnc-mg). In mice, conditional knockout of lnc-mg in skeletal muscle results in muscle atrophy and the loss of muscular endurance during exercise. Alternatively, skeletal muscle-specific overexpression of lnc-mg promotes muscle hypertrophy. In vitro analysis of primary skeletal muscle cells shows that lnc-mg increases gradually during myogenic differentiation and its overexpression improves cell differentiation. Mechanistically, lnc-mg promotes myogenesis, by functioning as a competing endogenous RNA (ceRNA) for microRNA-125b to control protein abundance of insulin-like growth factor 2. These findings identify lnc-mg as a novel noncoding regulator for muscle cell differentiation and skeletal muscle development.
                Bookmark

                Author and article information

                Contributors
                zhkidney@qq.com
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                18 September 2020
                18 September 2020
                2020
                : 11
                : 4467
                Affiliations
                [1 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Department of Emergency Medicine, The Second Xiangya Hospital, , Central South University, ; Changsha, Hunan People’s Republic of China
                [2 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Emergency Medicine and Difficult Diseases Institute, , Central South University, ; Changsha, Hunan People’s Republic of China
                [3 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Department of Ophthalmology, The Second Xiangya Hospital, , Central South University, ; Changsha, Hunan People’s Republic of China
                [4 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, , Central South University, ; Changsha, Hunan People’s Republic of China
                [5 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Department of Trauma center, The Second Xiangya Hospital, , Central South University, ; Changsha, Hunan People’s Republic of China
                [6 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Department of Urinary Surgery, The Second Xiangya Hospital, , Central South University, ; Changsha, Hunan People’s Republic of China
                [7 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Department of Chest Surgery, The Second Xiangya Hospital, , Central South University, ; Changsha, Hunan People’s Republic of China
                [8 ]GRID grid.263817.9, Department of Endocrinology, Shenzhen People’s Hospital, The Second Clinical Medical College of Jinan University, , The First Affiliated Hospital of Southern University of Science and Technology, ; Shenzhen, China
                [9 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Department of Metabolism and Endocrinology, Metabolic Syndrome Research Center, , Central South University, ; Changsha, Hunan People’s Republic of China
                [10 ]GRID grid.215352.2, ISNI 0000000121845633, Department of Pharmacology, , University of Texas Health at San Antonio, ; San Antonio, TX USA
                Author information
                http://orcid.org/0000-0001-8852-034X
                http://orcid.org/0000-0002-4712-4903
                http://orcid.org/0000-0002-5098-1711
                Article
                18304
                10.1038/s41467-020-18304-z
                7501299
                32948751
                78be9b67-2b65-4389-a7b9-1d3aa6c6f556
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 11 July 2019
                : 10 August 2020
                Funding
                Funded by:  National Natural Science Foundation of China[81870475, 81570646, and 81770951]
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                growth factor signalling,kidney,obstructive nephropathy
                Uncategorized
                growth factor signalling, kidney, obstructive nephropathy

                Comments

                Comment on this article